2007
DOI: 10.1136/thx.2006.057935
|View full text |Cite
|
Sign up to set email alerts
|

Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
1

Year Published

2008
2008
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(25 citation statements)
references
References 33 publications
0
24
1
Order By: Relevance
“…A few reports show a direct role for iNOS in the process of eosinophil recruitment in that inhibition of iNOS, either pharmacologically or by a gene knockout, reduces airway infiltration by inflammatory cells, especially eosinophils, in models of allergen-induced lung inflammation (reviewed in [25]). Furthermore, two very recent reports showed that polymorphisms in the iNOS gene may be important for asthma protection or susceptibility [11,12]. However, the results of a recent clinical trial conducted by SINGH et al [10] questioned the role of iNOS during asthma and the viability of iNOS as a therapeutic target to treat the symptoms of the disease.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A few reports show a direct role for iNOS in the process of eosinophil recruitment in that inhibition of iNOS, either pharmacologically or by a gene knockout, reduces airway infiltration by inflammatory cells, especially eosinophils, in models of allergen-induced lung inflammation (reviewed in [25]). Furthermore, two very recent reports showed that polymorphisms in the iNOS gene may be important for asthma protection or susceptibility [11,12]. However, the results of a recent clinical trial conducted by SINGH et al [10] questioned the role of iNOS during asthma and the viability of iNOS as a therapeutic target to treat the symptoms of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…SINGH et al [10] reported that iNOS inhibition with GW274150, a selective and potent iNOS inhibitor, effectively reduces exhaled breath NO but does not affect airway inflammatory cell numbers or airway hyperreactivity after allergen challenge in subjects with asthma. Interestingly, reports by HOLLA et al [11] and BATRA et al [12] show that polymorphisms in the iNOS gene may be important for asthma protection or susceptibility. Such conflicting reports undoubtedly suggest that additional studies are necessary to fully establish the intricate role(s) of NO and its metabolites during airway inflammation.…”
Section: Synthase (Nos): Neuronal Nos (Nnos); Endothelial Nos (Enos);mentioning
confidence: 99%
“…However, the present sample is exclusively of Czech Caucasian origin, restricted to the limited geographical area populated by a quite homogenous population with little admixture. Third, there are certainly other genes and polymorphisms – e.g., of superoxide dismutase, nitric oxide synthase, catalase – that could modulate antioxidant properties and thus are a predisposition to asthma [30,31,32,33,34], which have not been studied in the present case.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it may be stated that the inhibition of iNOS was due to NILE mediated inhibition of TNF-a. Under the influence of NILE, the decrease in the expression of IL-4 and NO may be beneficial for asthmatic patients, as both IL-4 and iNOS are associated with asthmatic conditions (Batra et al 2007).…”
Section: Discussionmentioning
confidence: 99%